ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19

https://storage.unitedwebnetwork.com/files/1099/ae87736974bf77c29ef5e8a0a5c53069.pdf
ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19
Jonathan
Barratt
Bart Maes bart.maes@azdelta.be AZ Delta Nephrology Roeselare
Rubeen Israni rubeen.israni@veratx.com Vera Therapeutics Clinical Development Brisbane
Xuelian Wei xuelian.wei@veratx.com Vera Therapeutics Biostatistics Brisbane
Vladimir Tesar vladimir.tesar@vfn.cz Charles University Nephrology Prague
Gerald Appel GBA2@cumc.columbia.edu Columbia University Nephrology New York
Yusuke Suzuki yusuke@juntendo.ac.jp Juntendo University Nephrology Tokyo
Celia Lin celia.lin@veratx.com Vera Therapeutics Medical Brisbane
Richard Lafayette czar@stanford.edu Stanford University Nephrology Stanford
 
 
 
 
 
 
 
E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos